Prevention and correction of behavioral disorders in rats with metabolic syndrome using a complex phytoadaptogen
https://doi.org/10.29413/ABS.2024-9.1.23
Abstract
The aim of the study. To assess the possibility of correction and prevention of behavioral disorders in rats with metabolic syndrome using a complex phytoadaptogen (CPA).
Material and methods. The experiment was carried out on 30 male Wistar rats randomized into 3 groups: group 1 – control; group 2 – metabolic syndrome (MS); group 3 – treatment of metabolic syndrome using CPA. In groups 2 and 3, animals were on a high-carbohydrate and high-fat diet for 16 weeks. Group 3 received CPA for 14 days in drinking water after 16 weeks of a diet. CPA consists of official tinctures of Glycyrrhiza glabra, Rhodiola rosea, Acantopanax senticosus at a ratio of 1:2:1. Behavior was analyzed through the “open field” test using Realtimer software (Open Science, Russia). Data were analyzed using GraphPad Prism 8.03 software (GraphPad, USA).
Results. The experiment proved that metabolic syndrome is accompanied by increased anxiety (decreased horizontal (p = 0.017) and vertical (p = 0.017) motor activity) and fear (increased periods of immobility (p = 0.011)) in the open field. When corrected with a complex phytoadaptogen, the time spent in the open and closed arms of the maze did not differ statistically significantly from the values of similar control indicators.
Conclusion. Based on the data obtained in the group 3 (no statistically significant differences with control) – decreased manifestations of fear and anxiety (increased orientation and research activity) – we can talk about the effectiveness of complex phytoadaptogens as an anxiolytic. The mechanisms underlying this result remain to be explored, emphasizing the role of the autonomic nervous system, leptin and ghrelin in behavior and the influence of complex phytoadaptogens on them.
About the Authors
Zh. V. Dzampaeva
Institute of Biomedical Researches – Branch of Vladikavkaz Scientific Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
Zhanna V. Dzampaeva – Junior Research Officer,
Pushkinskaya str. 47, Vladikavkaz 362045
F. S. Datieva
Institute of Biomedical Researches – Branch of Vladikavkaz Scientific Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
Fatima S. Datieva – Doctor of Medical Sciences, Leading Research Officer, Director,
Pushkinskaya str. 47, Vladikavkaz 362045
E. A. Takoeva
Institute of Biomedical Researches – Branch of Vladikavkaz Scientific Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
Elena A. Takoeva – Cand. Sc. (Med.), Research Officer,
Pushkinskaya str. 47, Vladikavkaz 362045
M. I. Nartikoeva
Institute of Biomedical Researches – Branch of Vladikavkaz Scientific Centre, Russian Academy of Sciences
Russian Federation
Russian Federation
Marina I. Nartikoeva – Junior Research Officer,
Pushkinskaya str. 47, Vladikavkaz 362045
References
1. Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017; 377: 13-27. doi: 10.1056/NEJMoa1614362
2. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018; 20(2): 12. doi: 10.1007/s11906-018-0812-z
3. Lyapina LA, Grigorjeva ME, Obergan TY, Myasoedov NF, Andreeva LA. Correction of manifestations of the experimental metabolic syndrome in rats with some arginine-containing peptides. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2017; 72(2): 92-98. (In Russ.).
4. Lavallee KL, Zhang XC, Schneider S, Margraf J. Obesity and mental health: A longitudinal, cross-cultural examination in Germany and China. Front Psychol. 2021; 12: 712567.
5. Monserrat-Mesquida М, Quetglas-Llabres М, Capo X, Bouzas C, Mateos D, Pons A, et al. Metabolic syndrome is associated with oxidative stress and proinflammatory state. Antioxidants (Basel). 2020; 9(3): 236. doi: 10.3390/antiox9030236
6. Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V, et al. High-сarbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011; 57(1): 51-64. doi: 10.1097/FJC.0b013e3181feb90a
7. Mulkey SB, du Plessis AJ. Autonomic nervous system development and its impact on neuropsychiatric outcome. Pediatr Res. 2019; 85(2): 120-126. doi: 10.1038/s41390-018-0155-0
8. Sadock BJ, Sadock VA. Kaplan & Sadock’s comprehensive textbook of psychiatry. Philadelphia: Lippincott Williams & Wilkins Publishers; 2000.
9. Panossian A, Seo EJ, Efferth Т. Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells. Phytomedicine. 2019; (1): 1528-1581. doi: 10.1016/j.phymed.2019.152881
10. Panossian AG, Efferth Т, Shikov AN, Pozharitskaya ON, Kuchta K, Mukherjee PK, et al. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Med Res Rev. 2020; 20(4): 1-74. doi: 10.1002/med.21743
11. Tian C, Hao L, Yi W, Ding S, Xu F. Polyphenols. Oxidative stress and metabolic syndrome. Gxid Med Cell Longev. 2020; 2020: 7398453. doi: 10.1155/2020/7398453
12. Zhang Y, Scarpace PJ. The role of leptin in leptin resistance and obesity. Physiol Behav. 2006; 88: 249-256. doi: 10.1016/j.physbeh.2006.05.038
13. Scarpace PJ, Matheny M, Kirichenko N, Gao YX, Tumer N, Zhang Y. Leptin overexpression in VTA trans-activates the hypothalamus whereas prolonged leptin action in either region crossdesensitizes. Neuropharmacology. 2013; 65: 90-100. doi: 10.1016/j.neuropharm.2012.09.005
14. Pertsov SS, Alekseeva IV, Abramova AYu, Nikenina EV, Kozlov AYu, Koplik EV, et al. Metabolic parameters in rats at various stages of the post-stress period under conditions of antigenic exposure by administration of lipopolysaccharide. Russian Journal of Physiology. 2021; 107(3): 321-331. (In Russ.). doi: 10.31857/S086981392103008
15. Pezze MA, Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Progr Neurobiol. 2004; 74: 301-320. doi: 10.1016/j.pneurobio.2004.09.004
16. Marazziti D, Rutigliano G, Baroni S, Landi P, Dell’Osso L. Metabolic syndrome and major depression. CNS Spectr. 2014; 19(4): 293-304. doi: 10.1017/S1092852913000667
17. Hasan MK, Mondal MSA, Kabir Y. Phytochemistry, pharmacological activity and potential health benefits of Glycyrrhiza glabra. Heliyon. 2021; 7(6): 07240. doi: 10.1016/j.heliyon.2021. e07240
18. Zheng Y, Lee J, Lee EH, In G, Kim J, Lee MH, et al. A combination of Korean red ginseng extract and Glycyrrhiza glabra L. extract enhances their individual anti-obesity properties in 3T3- L1 adipocytes and C57BL/6J obese mice. J Med Food. 2020; 23(3): 215-223. doi: 10.1002/med.21743
19. Li Z, Chen C, Zhu X, Li Y, Yu R, Xu W. Glycyrrhizin suppresses RANKL-Induced osteoclastogenesis and oxidative stress through inhibiting NF-kB and МАРК and activating AMPK/Nrf2. Calcif Tissue Int. 2018; 103(3): 324-327. doi: 10.1007/s00223-018-0425-1
20. Lee OH, Kwon YI, Apostolidis E, Shetty K, Kim YC. Rhodiolainduced inhibition of adipogenesis involves antioxidant enzyme response associated with pentose phosphate pathway. Phytother Res. 2011; 25(1): 106-115. doi: 10.1002/ptr.3236
Review
For citations:
Dzampaeva Zh.V., Datieva F.S., Takoeva E.A., Nartikoeva M.I. Prevention and correction of behavioral disorders in rats with metabolic syndrome using a complex phytoadaptogen. Acta Biomedica Scientifica. 2024;9(1):233-240. (In Russ.) https://doi.org/10.29413/ABS.2024-9.1.23
Views:
397
.png)
Email this article 
